CNTX logo

Context Therapeutics (CNTX) EBIT

Annual EBIT

-$25.07 M
-$10.19 M-68.49%

December 31, 2023


Summary


Performance

CNTX EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCNTXprofitabilitymetrics:

Quarterly EBIT

-$18.70 M
-$15.61 M-505.52%

September 1, 2024


Summary


Performance

CNTX Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCNTXprofitabilitymetrics:

TTM EBIT

-$32.55 M
-$12.52 M-62.52%

September 1, 2024


Summary


Performance

CNTX TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCNTXprofitabilitymetrics:

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

CNTX EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-68.5%0.0%0.0%
3 y3 years-443.2%0.0%0.0%
5 y5 years-374.5%0.0%0.0%

CNTX EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-141.3%at low-505.5%at low-213.2%at low
5 y5-year-443.2%at low-345.0%at low-470.8%at low
alltimeall time-443.2%at low-345.0%at low-470.8%at low

Context Therapeutics EBIT History

DateAnnualQuarterlyTTM
Sep 2024
-
-$18.70 M(+505.5%)
-$32.55 M(+62.5%)
Jun 2024
-
-$3.09 M(-19.2%)
-$20.03 M(-9.9%)
Mar 2024
-
-$3.82 M(-44.9%)
-$22.23 M(-11.3%)
Dec 2023
-$25.07 M(+68.5%)
-$6.93 M(+12.2%)
-$25.07 M(+13.9%)
Sep 2023
-
-$6.18 M(+16.8%)
-$22.02 M(+10.7%)
Jun 2023
-
-$5.29 M(-20.6%)
-$19.89 M(+9.9%)
Mar 2023
-
-$6.67 M(+71.7%)
-$18.10 M(+21.7%)
Dec 2022
-$14.88 M
-$3.88 M(-4.1%)
-$14.88 M(-12.7%)
Sep 2022
-
-$4.05 M(+15.4%)
-$17.05 M(+17.0%)
Jun 2022
-
-$3.51 M(+1.9%)
-$14.57 M(+12.1%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$3.44 M(-43.1%)
-$13.00 M(+25.0%)
Dec 2021
-$10.39 M(-242.3%)
-$6.05 M(+285.6%)
-$10.39 M(+106.3%)
Sep 2021
-
-$1.57 M(-19.1%)
-$5.04 M(+18.5%)
Jun 2021
-
-$1.94 M(+130.6%)
-$4.25 M(-179.8%)
Mar 2021
-
-$840.30 K(+21.7%)
$5.32 M(-27.1%)
Dec 2020
$7.31 M(-238.3%)
-$690.30 K(-11.6%)
$7.31 M(-8.6%)
Sep 2020
-
-$781.00 K(-110.2%)
$8.00 M(-8.9%)
Jun 2020
-
$7.63 M(+568.2%)
$8.78 M(+668.2%)
Mar 2020
-
$1.14 M
$1.14 M
Dec 2019
-$5.28 M
-
-

FAQ

  • What is Context Therapeutics annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Context Therapeutics?
  • What is Context Therapeutics annual EBIT year-on-year change?
  • What is Context Therapeutics quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Context Therapeutics?
  • What is Context Therapeutics quarterly EBIT year-on-year change?
  • What is Context Therapeutics TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Context Therapeutics?
  • What is Context Therapeutics TTM EBIT year-on-year change?

What is Context Therapeutics annual earnings before interest & taxes?

The current annual EBIT of CNTX is -$25.07 M

What is the all time high annual EBIT for Context Therapeutics?

Context Therapeutics all-time high annual earnings before interest & taxes is $7.31 M

What is Context Therapeutics annual EBIT year-on-year change?

Over the past year, CNTX annual earnings before interest & taxes has changed by -$10.19 M (-68.49%)

What is Context Therapeutics quarterly earnings before interest & taxes?

The current quarterly EBIT of CNTX is -$18.70 M

What is the all time high quarterly EBIT for Context Therapeutics?

Context Therapeutics all-time high quarterly earnings before interest & taxes is $7.63 M

What is Context Therapeutics quarterly EBIT year-on-year change?

Over the past year, CNTX quarterly earnings before interest & taxes has changed by $0.00 (0.00%)

What is Context Therapeutics TTM earnings before interest & taxes?

The current TTM EBIT of CNTX is -$32.55 M

What is the all time high TTM EBIT for Context Therapeutics?

Context Therapeutics all-time high TTM earnings before interest & taxes is $8.78 M

What is Context Therapeutics TTM EBIT year-on-year change?

Over the past year, CNTX TTM earnings before interest & taxes has changed by $0.00 (0.00%)